vimarsana.com

Page 3 - மருந்துகள் ப்ரைஸ் கட்டுப்பாடு ஆர்டர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bring Remdesivir under drug price control: Maha Barrister

Bring Remdesivir under drug price control: Maha Barrister ​ Fri, Apr 16 2021 8:21 IST | ​ 5 Views   Mumbai, April 16 : A prominent Maharashtra legal luminary has petitioned the Centre to declare the Remdesivir medicine - currently in huge demand owing to the Covid-19 pandemic - as a life-saving medicine with controlled pricing to prevent blackmarketing and corruption. Remdesivir is manufactured by a handful of companies under brand names like Cipremi (Cipla), Covifar (Hetero), Desrem (Mylon), Remdac (Zydus), Redyx (Dr. Reddy s). In a plea to the Central Government which controls the National Pharmaceutical Pricing Authority (NPPA), a statutory authority under the Drugs Price Control Order (DPCO), Mumbai Barrister Vinod Tiwari on Thursday demanded a high-level investigation into the artificial scarcity, hoarding, blackmarketing and misuse of the drug which could run into a racket of over Rs 25,000-crore under the nose of the NPPA, in the past ten months since the drug

Bring life-saver Remdesivir under drug price control: Maha Barrister

Bring life-saver Remdesivir under drug price control: Maha Barrister
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.

Hospitals profiteering by selling Remdesivir at printed rate: Maharashtra

Read more about Hospitals profiteering by selling Remdesivir at printed rate: Maharashtra on Business Standard. Several hospitals in Maharashtrahave been recovering the printed price of Remdesivir injections, used for COVID-19 treatment, from the patients and making profit, officials said on Thursday.The Food and Drugs Administration (FDA) has now

Budget 2021: Healthcare gets biggest boost, but some expectations remain unmet

Budget 2021: Healthcare gets biggest boost, but some expectations remain unmet Budget 2021 has taken care of the bare necessities that are needed to ensure that the healthcare infrastructure of the country is given a booster dose to make it infallible to pandemics like what we are going through Ashwin Sapra | February 3, 2021 | Updated 11:46 IST Budget 2021 is a good enough step in this direction. Now time will tell how these steps eventually pan out The year 2020 was like no other. The world was ravaged by a deadly virus which brought economies of the world to a standstill. The inadequacies of healthcare infrastructure were exposed. We struggled to deal with the pandemic and by the time effective measures were put in place, many lives were lost.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.